Workflow
Repligen(RGEN) - 2022 Q3 - Quarterly Report
RGENRepligen(RGEN)2022-11-01 20:31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 REPLIGEN CORPORATION (Exact Name of Registrant as Specified in its Charter) Delaware 04-2729386 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 41 Seyon Street, Bldg. 1, Suite 100 Waltham, MA 02453 (Address of Principal Executive Offices) (Zip Code) For the quarterly period ended September ...